[54 Pages Report] The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period. Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.
Based on system, the market is segmented into integrated and standalone systems. The integrated systems segment is projected to witness the highest growth during the forecast period. The increasing adoption of integrated systems by healthcare providers is the major factor supporting the growth of this segment.
By component, the market is segmented into software, services, and hardware. The software segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the growing need to integrate CVIS with C-PACS, EMRs, and other cardiology modules.
Based on end user, the market is segmented into L3A hospitals and L3B & L2 Hospitals. The L3A hospitals segment accounted for the largest share of the market in 2018. The increasing number of L3A hospitals in China and growing disease prevalence are responsible for the large share of this market segment.
Key players in the China cardiology information system market are Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea) and Esaote (Italy).
In 2018, CREALIFE Medical Technology held the leading position in the market. The company has good relations with government bodies, distributors, and hospitals in the market, which is its key strength. Philips Healthcare held the second position in the market in 2018.
Market size available for years
Base year considered
Major players covered, including Philips Healthcare (Netherland), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).
This research report categorizes the market into the following segments and subsegments:
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1.2 Objectives of the Study
2 Research Methodology
3 Market Overview
3.2.1 Rising Incidence and Prevalence of Cardiovascular Disease in China
3.2.2 Increasing Number of Hospitals in China
3.2.3 Favorable Government Initiatives
3.3.1 Use of Cloud-Based Solutions
3.4.1 Integration and Interoperability
4 China Cardiology Information System Market, By System
4.1 Integrated Systems
4.2 Standalone Systems
5 China Cardiology Information System Market, By Component
6 China Cardiology Information System Market, By End User Analysis
6.2 L3A Hospitals
6.3 L3B & L2 Hospitals
6.4 Level 1 Hospitals
7 China Cardiology Information System Market, By End User Analysis
7.1 Market Share Analysis, 2018
7.2 China: Cardiology Information Technology Market Share Analysis for Individual Players, By Hospital Type (2018)
8 China Cardiology Information System Market, Company Profiles
8.1 Philips Healthcare
8.1.1 Company Overview
8.1.2 Products Offered in China
8.1.3 Business Overview
8.1.4 SWOT Analysis
8.2 Crealife Medical Technology
8.2.1 Company Overview
8.2.2 Products Offered in China
8.2.3 SWOT Analysis
8.3 Central Data Networks
8.3.1 Company Overview
8.3.2 Products Offered in China
8.3.3 SWOT Analysis
8.4 Esaote China Ltd.
8.4.1 Company Overview
8.4.2 Products Offered in China
8.5 Infinitt Healthcare Co., Ltd.
8.5.1 Company Overview
8.5.2 Products Offered in China
9 Key Insights From Industry Participants
10.1 Discussion Guide
10.2 Knowledge Store: Marketssandmarkets’ Subscription Portal
10.3 Related Reports
10.4 Authors Details
List of Tables (7 Tables)
Table 1 China: Cardiology Information Technology Market, By System, 2017–2024 (USD Million)
Table 2 China: Cardiology Information Technology Market, By Component, 2017–2024 (USD Million)
Table 3 Number of Hospitals in China, 2009–2024
Table 4 China: Cardiology Information Technology Market, By End User, 2017–2024 (USD Million)
Table 5 Increasing Number of L3A Hospitals in China, 2009–2024
Table 6 Increasing Number of L3B & L2 Hospitals in China, 2009–2024
Table 7 China: Average Selling Price of Cardiovascular Information Technology, By End User (USD Million)
List of Figures (8 Figures)
Figure 1 Data Triangulation Methodology
Figure 2 Mortlity Rate Due to Heart Disease in China
Figure 3 Number of Hospitals in China (In Thousand)
Figure 4 Private vs Public Hospitals in China (In Thousand)
Figure 5 Healthcare Expenditure in China (In USD)
Figure 6 China Cardiology Information Technology Market Share Analysis By Key Players, 2018
Figure 7 China Cardiology Information Technology Market Share Analysis for Individual Players By Hospital Type, 2018
Figure 8 Philips Healthcare: Company Snapshot (2018)
The study involved four major activities in estimating the current market size of the China cardiology information system market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg, and Factiva) were referred to identify and collect information for this study.
The market comprises several stakeholders, such as cardiology information system manufacturers, vendors, and distributors. The demand side of this market is characterized by the significant use of cardiology information systems. Advancements in technology characterize the supply side. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. A breakdown of primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the China cardiology information system market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Benchmarking the rapid strategy shifts of the Top 100 companies in the Cardiology Information System (CIS) MarketRequest For Special Pricing